Abstract
We evaluated the harvest product from 47 patients undergoing peripheral blood (BP) stem cell collections for monoclonal plasma cells (PC) using a sensitive immunofluorescence technique. 60% (28/47) had docu mented tumour cells in the apheresis product. The 32 patients in plateau had a mean of 1.62 x 106 PC/1 v 74.64 x 106 in 15 relapsed patients (P < 0.01). 32% (6/19) of patients without any tumour cells in the initial sample had them detected on a subsequent apheresis sample. In four cases (all treated with GM‐CSF) small numbers of tumour cells were detected initially but became undetectable on a subsequent sample.
Original language | English (US) |
---|---|
Pages (from-to) | 640-642 |
Number of pages | 3 |
Journal | British journal of haematology |
Volume | 89 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1995 |
Keywords
- autologous transplant
- multiple myeloma
- stem cells
ASJC Scopus subject areas
- Hematology